Majority of the patients were on 2 drugs for the control of diabetes (55.2%, n = 91), and the most common drug used was metformin (81.8%, n = 135), followed by gliclazide (38.2%, n = 63), and insulin (33.9%, n = 56). This evidence concerns the gene INS and diabetes mellitus.